Ann: Appendix 4C - Quarter Ended 30 September 201, page-2

  1. 130 Posts.
    re: Ann: Appendix 4C - Quarter Ended 30 Septe... The main (good) thing: QRX have suspended all "pipeline" projects so as to conserve cash while the immediate release Moxduo is before the FDA decision, estimated mid 2013. IMO that shows pragmatic fiscal responsibility towards gaining a positive FDA resul as well as shareholders (us).
    Based on the above premise, QRX are financially self reliant to about November 2013.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.